EUVIMEDEUVIMED entdecken
Crossref

Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria

Cecilia Bonazzetti iD, Matteo Rinaldi iD, Federica Cosentino, Milo Gatti iD, Maristela Pinheiro Freire iD, Alessandra Mularoni iD, Wanessa Trindade Clemente, Ligia Camera Pierrotti iD, Jose Maria Aguado iD, Paolo Grossi iD, Federico Pea, Pierluigi Viale und 2 weitere

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Cecilia Bonazzetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Kidney Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Performance of active screening for multidrug‐resistant Gram‐negative bacteria (MDR‐GNB) and administration of targeted antibiotic prophylaxis (TAP) in colonized patients undergoing liver (LT) and/or kidney transplantation (KT) are controversial issues.

Methods

Self‐administered electronic cross‐sectional survey disseminated from January to February 2022. Questionnaire consisted of four parts: hospital/transplant program characteristics, standard screening and antibiotic prophylaxis, clinical vignettes asking for TAP in patients undergoing LT and KT with prior infection/colonization with four different MDR‐GNB (extended‐spectrum cephalosporin‐resistant Enterobacterales [ESCR‐E], carbapenem‐resistant Enterobacterales [CRE], multidrug‐resistant Pseudomonas aeruginosa [MDR‐Pa], and carbapenem‐resistant Acinetobacter baumannii [CRAb]).

Results

Fifty‐five respondents participated from 14 countries, mostly infectious disease specialists (69%) with active transplant programs (>100 procedures/year for 34.5% KT and 23.6% LT), and heterogeneous local MDR‐GNB prevalence from 30% (16.4%). The frequency of screening for ESCR‐E, CRE, MDR‐Pa, and CRAb was 22%, 54%, 17%, and 24% for LT, respectively, and 18%, 36%, 16%, and 11% for KT. Screening time‐points were mainly at transplantation 100%, only one‐third following transplantation. Screening was always based on rectal swab cultures (100%); multi‐site sampling was reported in 40% of KT and 35% of LT. In LT clinical cases, 84%, 58%, 84%, and 40% of respondents reported TAP for prior infection/colonization with ESCR‐E, CRE, MDR‐Pa, and CRAb, respectively. In KT clinical cases, 55%, 39%, 87%, and 42% of respondents reported TAP use for prior infection/colonization with ESCR‐E, CRE, MDR‐Pa, and CRAb, respectively.

Conclusion

There is a large heterogeneity in screening and management of MDR‐GNB carriage in LT and KT. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gram-Negative Bacterial InfectionsKidney TransplantationHumansAntibiotic ProphylaxisCross-Sectional StudiesGram-Negative BacteriaAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialLiverCarbapenemsSurveys and Questionnaires

Stichwörter der Autor:innen

colonizationmultidrug‐resistant Gram‐negative bacteriaprophylaxisscreeningtransplantation

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Infectious Diseases Unit, IRCCS Policlinico Sant'Orsola, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Working Committee for Hospital Epidemiology and Infection Control, Hospital das Clinicas, Universidade de São Paulo, Sao Paulo, Brazil.
  • Unit of Infectious Diseases, IRCCS-ISMETT Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy.
  • Department of Laboratory Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

ORCID-Profile: Cecilia Bonazzetti, Matteo Rinaldi, Milo Gatti, Maristela Pinheiro Freire, Alessandra Mularoni, Ligia Camera Pierrotti, Jose Maria Aguado, Paolo Grossi, Maddalena Giannella

Zitieren

APA

Bonazzetti, C., Rinaldi, M., Cosentino, F., Gatti, M., Freire, M. P., Mularoni, A., Clemente, W. T., Pierrotti, L. C., Aguado, J. M., Grossi, P., Pea, F., Viale, P., Giannella, M., & European Study Group of Infections in Immunocompromised Host (2024). Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria. Transplant Infectious Disease. https://doi.org/10.1111/tid.14238

Vancouver

Bonazzetti C, Rinaldi M, Cosentino F, Gatti M, Freire MP, Mularoni A, et al. Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria. Transplant Infectious Disease. 2024. doi:10.1111/tid.14238

BibTeX
@article{Bonazzetti2024,
  author = {Bonazzetti, Cecilia and Rinaldi, Matteo and Cosentino, Federica and Gatti, Milo and Freire, Maristela Pinheiro and Mularoni, Alessandra and Clemente, Wanessa Trindade and Pierrotti, Ligia Camera and Aguado, Jose Maria and Grossi, Paolo and Pea, Federico and Viale, Pierluigi and Giannella, Maddalena and European Study Group of Infections in Immunocompromised Host, European Study Group of Infections in Immunocompromised Host},
  title = {Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14238}
}
Kostenlos starten →